Bhageria & Jajodia Pharmaceuticals Private Limited logo

Bhageria & Jajodia Pharmaceuticals Private Limited

Founded in 2008 headquartered in Maharashtra, India.
2008 | Mumbai, Maharashtra (India) | Active

Last Updated:

July 29, 2024
HomeCompanyBhageria & Jajodia Pharmaceuticals Private Limited

Who are the key members and board of directors at Bhageria & Jajodia Pharmaceuticals?

Board Members(4)

NameDesignationAppointment DateStatus
Vinay Matoliya In Director 28-Jan-2022Current
Rahul Bhageria In Director 09-Sep-2021Current
Vikas Bhageria In Director 08-Sep-2015Current
Ashish Kejdiwal In Director 18-Sep-2021Current

Financial Performance and Corporate Structure Insights of Bhageria & Jajodia Pharmaceuticals.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹150.00 M

LenderAmountStatus

Yes Bank Limited

Creation Date: 12 Oct 2023
₹15.00 CrOpen

How Many Employees Work at Bhageria & Jajodia Pharmaceuticals?

Unlock and access historical data on people associated with Bhageria & Jajodia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Bhageria & Jajodia Pharmaceuticals

Recent activity within the organization

  • Charges

    A charge with Yes Bank Limited amounted to Rs. 150.00 M with Charge ID 100795463 was registered on 12 Oct 2023.

    12 Oct 2023

  • Annual General Meeting

    Bhageria & Jajodia Pharmaceuticals Private Limited last Annual general meeting of members was held on 09 Sep 2023 as per latest MCA records.

    09 Sep 2023

  • Balance Sheet

    Bhageria & Jajodia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

    31 Mar 2023

  • Director Appointment

    Vinay Banwarilal Matoliya was appointed as a Director was appointed as a Director on 28 Jan 2022 & has been associated with this company since 2 years 10 months .

    28 Jan 2022

  • Director Appointment

    Ashish Vishwanth Kejdiwal was appointed as a Director was appointed as a Director on 18 Sep 2021 & has been associated with this company since 3 years 3 months .

    18 Sep 2021

  • Director Appointment

    Rahul Niranjanlal Bhageria was appointed as a Director was appointed as a Director on 09 Sep 2021 & has been associated with this company since 3 years 3 months .

    09 Sep 2021

Frequently asked questions

  • Bhageria & Jajodia Pharmaceuticals Private Limited was incorporated on 09 Feb 2008.

  • The authorized share capital of Bhageria & Jajodia Pharmaceuticals Private Limited is ₹ 5.00 M and paid-up capital is ₹ 5.00 M.

  • Currently 4 directors are associated with Bhageria & Jajodia Pharmaceuticals Private Limited.

    • Rahul Niranjanlal Bhageria
    • Vikas Sureshkumar Bhageria
    • Vinay Banwarilal Matoliya
    • Ashish Vishwanth Kejdiwal
  • As per Ministry of Corporate Affairs (Mca), the registered address of Bhageria & Jajodia Pharmaceuticals Private Limited is 1001 10Th Floor Topiwala Centre Opp. S.V.Road Near Railway Station Gor, Egaon West, Mumbai, Maharashtra, India, 400062.

  • The corporate identification number (CIN) of Bhageria & Jajodia Pharmaceuticals Private Limited is U24100MH2008PTC178713 and the company number is 178713 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Bhageria & Jajodia Pharmaceuticals Private Limited is https://www.bhageriagroup.com

  • As per the financial statements for fiscal Year , The total open charges for Bhageria & Jajodia Pharmaceuticals Private Limited amount to ₹ 15.00 Cr.

  • The most recent Balance Sheet for Bhageria & Jajodia Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

Similar Companies Based on Drug Formulation & Development